| [1] |
WANG TT, LU CL, FAN XL, et al. Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis[J]. J Clin Hepatol, 2017, 33(11): 2179-2185. DOI: 10.3969/j.issn.1001-5256.2017.11.026. |
| [2] |
TRIVEDI PJ, HIRSCHFIELD GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases[J]. Gut, 2021, 70(10): 1989-2003. DOI: 10.1136/gutjnl-2020-322362. |
| [3] |
CORDELL HJ, FRYETT JJ, UENO K, et al. Corrigendum to An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs[J]. J Hepatol, 2022, 76(2): 489. DOI: 10.1016/j.jhep.2021.11.015. |
| [4] |
GONZALEZ RS, WASHINGTON K. Primary biliary cholangitis and autoimmune hepatitis[J]. Surg Pathol Clin, 2018, 11(2): 329-349. DOI: 10.1016/j.path.2018.02.010. |
| [5] |
GULAMHUSEIN AF, JURAN BD, ATKINSON EJ, et al. Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up[J]. Liver Int, 2016, 36(9): 1378-1382. DOI: 10.1111/liv.13143. |
| [6] |
ZOGRAFOS TA, GATSELIS N, ZACHOU K, et al. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients[J]. World J Gastroenterol, 2012, 18(34): 4721-4728. DOI: 10.3748/wjg.v18.i34.4721. |
| [7] |
ÖRNOLFSSON KT, OLAFSSON S, BERGMANN OM, et al. Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis[J]. Hepatology, 2018, 68(1): 166-171. DOI: 10.1002/hep.29675. |
| [8] |
SELMI C, MAYO MJ, BACH N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment[J]. Gastroenterology, 2004, 127(2): 485-492. DOI: 10.1053/j.gastro.2004.05.005. |
| [9] |
SELMI C, BALKWILL DL, INVERNIZZI P, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium[J]. Hepatology, 2003, 38(5): 1250-1257. DOI: 10.1053/jhep.2003.50446. |
| [10] |
LIU HY, DENG AM, ZHOU Y, et al. Analysis of HLA alleles polymorphism in Chinese patients with primary biliary cirrhosis[J]. Hepatobiliary Pancreat Dis Int, 2006, 5(1): 129-132.
|
| [11] |
XU H, ZHANG S, HUANG L, et al. Identification of novel variants in the FZD4 gene associated with familial exudative vitreoretinopathy in Chinese families[J]. Clin Exp Ophthalmol, 2020, 48(3): 356-365. DOI: 10.1111/ceo.13690. |
| [12] |
HW XQ, ZHANG YF, YU JJ, et al. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway[J]. Tumour Biol, 2017, 39(3): 1-10. DOI: 10.1177/1010428317695971. |
| [13] |
SCHWABE RF, TABAS I, PAJVANI UB. Mechanisms of fibrosis development in nonalcoholic steatohepatitis[J]. Gastroenterology, 2020, 158(7): 1913-1928. DOI: 10.1053/j.gastro.2019.11.311. |
| [14] |
ESMAIL MM, SAEED NM, MICHEL HE, et al. The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways[J]. Toxicol Lett, 2021, 347: 23-35. DOI: 10.1016/j.toxlet.2021.04.018. |
| [15] |
CROQUELOIS A, BLINDENBACHER A, TERRACCIANO L, et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice[J]. Hepatology, 2005, 41(3): 487-496. DOI: 10.1002/hep.20571. |
| [16] |
ZHANG X, DU G, XU Y, et al. Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes[J]. Lab Invest, 2016, 96(3): 350-360.
|
DownLoad:
